{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:58:54Z","timestamp":1787968734701,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01112-4","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:37:02Z","timestamp":1779712622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical efficacy analysis of secukinumab combined with calcipotriol cream in the treatment of moderate to severe psoriasis in elderly patients"],"prefix":"10.1186","volume":"27","author":[{"given":"Ling","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"9997","key":"1112_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP. Psoriasis. Lancet. 2015;386(9997):983\u201394.","journal-title":"Lancet"},{"key":"1112_CR2","doi-asserted-by":"crossref","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6).","DOI":"10.3390\/ijms20061475"},{"issue":"8","key":"1112_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/14712598.2018.1504016","volume":"18","author":"V Di Lernia","year":"2018","unstructured":"Di Lernia V, Goldust M. An overview of the efficacy and safety of systemic treatments for psoriasis in the elderly. Expert Opin Biol Ther. 2018;18(8):897\u2013903.","journal-title":"Expert Opin Biol Ther"},{"issue":"10281","key":"1112_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397(10281):1301\u201315.","journal-title":"Lancet"},{"issue":"3","key":"1112_CR5","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1080\/09546634.2020.1809623","volume":"33","author":"K Bakirtzi","year":"2022","unstructured":"Bakirtzi K, Sotiriou E, Papadimitriou I, Sideris N, Vakirlis E, Lallas A, Vrani F, Ioannides D. Elderly patients with psoriasis: long-term efficacy and safety of modern treatments. J Dermatolog Treat. 2022;33(3):1339\u201342.","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"1112_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2165\/00002512-199812030-00002","volume":"12","author":"C Bonifati","year":"1998","unstructured":"Bonifati C, Carducci M, Mussi A, D\u2019Auria L, Ameglio F. Recognition and treatment of psoriasis. Special considerations in elderly patients. Drugs Aging. 1998;12(3):177\u201390.","journal-title":"Drugs Aging"},{"issue":"12","key":"1112_CR7","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1080\/14712598.2022.2089020","volume":"22","author":"M Megna","year":"2022","unstructured":"Megna M, Potestio L, Fabbrocini G, Camela E. Treating psoriasis in the elderly: biologics and small molecules. Expert Opin Biol Ther. 2022;22(12):1503\u201320.","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"1112_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14740338.2023.2173171","volume":"22","author":"M Megna","year":"2023","unstructured":"Megna M, Camela E, Battista T, Genco L, Martora F, Noto M, Picone V, Ruggiero A, Monfrecola G, Fabbrocini G, et al. Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opin Drug Saf. 2023;22(1):43\u201358.","journal-title":"Expert Opin Drug Saf"},{"issue":"18","key":"1112_CR9","doi-asserted-by":"publisher","first-page":"adv00316","DOI":"10.2340\/00015555-3678","volume":"100","author":"C Phan","year":"2020","unstructured":"Phan C, Beneton N, Delaunay J, Reguiai Z, Boulard C, Fougerousse AC, Cinotti E, Romanelli M, Mery-Bossard L, Thomas-Beaulieu D, et al. Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis. Acta Derm Venereol. 2020;100(18):adv00316.","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"1112_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/exd.14822","volume":"32","author":"F Rosset","year":"2023","unstructured":"Rosset F, Mastorino L, Dapavo P, Quaglino P, Ribero S. Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis. Exp Dermatol. 2023;32(7):1162\u20134.","journal-title":"Exp Dermatol"},{"key":"1112_CR11","doi-asserted-by":"crossref","unstructured":"Glazer Levavi S, Maman R, Sherman S, Mimouni D, Pavlovsky L. Systemic biologic treatment for psoriasis in elderly patients. J Clin Med. 2025;14(13).","DOI":"10.3390\/jcm14134779"},{"key":"1112_CR12","doi-asserted-by":"publisher","first-page":"367475","DOI":"10.1155\/2012\/367475","volume":"2012","author":"JW Wong","year":"2012","unstructured":"Wong JW, Koo JY. The safety of systemic treatments that can be used for geriatric psoriasis patients: a review. Dermatol Res Pract. 2012;2012:367475.","journal-title":"Dermatol Res Pract"},{"issue":"1","key":"1112_CR13","doi-asserted-by":"publisher","first-page":"e14704","DOI":"10.1111\/dth.14704","volume":"34","author":"A Polat Ekinci","year":"2021","unstructured":"Polat Ekinci A, B\u00f6l\u00fck KN, Babuna Kobaner G. Secukinumab and acitretin as a combination therapy for three clinical forms of severe psoriasis in multi-drug refractory patients: A case series of high efficacy and safety profile. Dermatol Ther. 2021;34(1):e14704.","journal-title":"Dermatol Ther"},{"issue":"4","key":"1112_CR14","doi-asserted-by":"publisher","first-page":"300060524124770","DOI":"10.1177\/03000605241247702","volume":"52","author":"J Li","year":"2024","unstructured":"Li J, Wang S, Li XD, Han Y. Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature. J Int Med Res. 2024;52(4):3000605241247702.","journal-title":"J Int Med Res"},{"issue":"4","key":"1112_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/NEJMoa1314258","volume":"371","author":"RG Langley","year":"2014","unstructured":"Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, et al. Secukinumab in plaque psoriasis\u2013results of two phase 3 trials. N Engl J Med. 2014;371(4):326\u201338.","journal-title":"N Engl J Med"},{"issue":"3","key":"1112_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1112_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-4632.2011.04979.x","volume":"51","author":"HH Kwon","year":"2012","unstructured":"Kwon HH, Kwon IH, Youn JI. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype? Int J Dermatol. 2012;51(1):53\u20138.","journal-title":"Int J Dermatol"},{"issue":"6","key":"1112_CR18","first-page":"587","volume":"151","author":"M Napolitano","year":"2016","unstructured":"Napolitano M, Balato N, Ayala F, Patruno C, Patr\u00ec A, Megna M, Balato A. Psoriasis in elderly and non-elderly population: clinical and molecular features. G Ital Dermatol Venereol. 2016;151(6):587\u201395.","journal-title":"G Ital Dermatol Venereol"},{"issue":"6","key":"1112_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.abd.2023.12.004","volume":"99","author":"E Acer","year":"2024","unstructured":"Acer E, Erdo\u011fan HK, A\u011fao\u011flu E, Ba\u015ft\u00fcrk H, Bilgin M, Sara\u00e7o\u011flu ZN. Efficacy and safety of secukinumab in psoriasis: five-year real life experience. Bras Dermatol. 2024;99(6):840\u20136.","journal-title":"Bras Dermatol"},{"issue":"10","key":"1112_CR20","doi-asserted-by":"publisher","first-page":"adv00576","DOI":"10.2340\/00015555-3816","volume":"101","author":"A Costanzo","year":"2021","unstructured":"Costanzo A, Russo F, Galluzzo M, Stingeni L, Scuderi R, Zichichi L, Papini M, Di Costanzo L, Conti A, Burlando M, et al. Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study. Acta Derm Venereol. 2021;101(10):adv00576.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"1112_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40266-014-0156-6","volume":"31","author":"N Balato","year":"2014","unstructured":"Balato N, Patruno C, Napolitano M, Patr\u00ec A, Ayala F, Scarpa R. Managing moderate-to-severe psoriasis in the elderly. Drugs Aging. 2014;31(4):233\u20138.","journal-title":"Drugs Aging"},{"issue":"6","key":"1112_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/1346-8138.15737","volume":"48","author":"IL Tseng","year":"2021","unstructured":"Tseng IL, Yang CC, Lai EC, Lee CN. Psoriasis in the geriatric population: A retrospective study in Asians. J Dermatol. 2021;48(6):818\u201324.","journal-title":"J Dermatol"},{"issue":"8","key":"1112_CR23","doi-asserted-by":"publisher","first-page":"e15628","DOI":"10.1111\/dth.15628","volume":"35","author":"P Asili","year":"2022","unstructured":"Asili P, Tootoonchi N, Nasimi M, Daneshpajooh M, Sedaghatzadeh M, Mirahmad M. Demographic aspects, clinical characteristics, and therapeutic approaches in geriatric psoriasis: A study from a tertiary center. Dermatol Ther. 2022;35(8):e15628.","journal-title":"Dermatol Ther"},{"issue":"10","key":"1112_CR24","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1517\/14656566.6.10.1725","volume":"6","author":"CS Lee","year":"2005","unstructured":"Lee CS, Koo J. A review of acitretin, a systemic retinoid for the treatment of psoriasis. Expert Opin Pharmacother. 2005;6(10):1725\u201334.","journal-title":"Expert Opin Pharmacother"},{"key":"1112_CR25","doi-asserted-by":"crossref","unstructured":"Das K, Daveluy S, Kroumpouzos G, Agarwal K, Podder I, Farnbach K, Ortega-Loayza AG, Szepietowski JC, Grabbe S, Goldust M. Efficacy and toxicity of classical immunosuppressants, retinoids and biologics in hidradenitis suppurativa. J Clin Med. 2022;11(3).","DOI":"10.3390\/jcm11030670"},{"issue":"12","key":"1112_CR26","doi-asserted-by":"publisher","first-page":"e1444","DOI":"10.1111\/jdv.19355","volume":"37","author":"G Fiorillo","year":"2023","unstructured":"Fiorillo G, Ibba L, Gargiulo L, Vignoli CA, Alfano A, Cortese A, Toso F, Orsini D, Iacovelli P, Frascione P, et al. Effectiveness and safety of anti-IL-23 and anti-IL-17 biological therapies for psoriasis in elderly patients: Real-world experience from two Italian hospitals. J Eur Acad Dermatol Venereol. 2023;37(12):e1444\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"1112_CR27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/ced.14258","volume":"45","author":"M Megna","year":"2020","unstructured":"Megna M, Camela E, Cinelli E, Fabbrocini G. Real-life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2-year period. Clin Exp Dermatol. 2020;45(7):848\u201352.","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"1112_CR28","first-page":"e129","volume":"12","author":"S Segaert","year":"2013","unstructured":"Segaert S, Ropke M. The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis. J Drugs Dermatol. 2013;12(8):e129\u2013137.","journal-title":"J Drugs Dermatol"},{"issue":"8","key":"1112_CR29","first-page":"46","volume":"3","author":"GK Kim","year":"2010","unstructured":"Kim GK. The rationale behind topical vitamin d analogs in the treatment of psoriasis: where does topical calcitriol fit in? J Clin Aesthet Dermatol. 2010;3(8):46\u201353.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"1112_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40266-018-0520-z","volume":"35","author":"A K\u00f6rber","year":"2018","unstructured":"K\u00f6rber A, Papavassilis C, Bhosekar V, Reinhardt M. Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies. Drugs Aging. 2018;35(2):135\u201344.","journal-title":"Drugs Aging"},{"issue":"2","key":"1112_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa2102383","volume":"385","author":"K Reich","year":"2021","unstructured":"Reich K, Warren RB, Lebwohl M, Gooderham M, Strober B, Langley RG, Paul C, De Cuyper D, Vanvoorden V, Madden C, et al. Bimekizumab versus Secukinumab in Plaque Psoriasis. N Engl J Med. 2021;385(2):142\u201352.","journal-title":"N Engl J Med"},{"issue":"2","key":"1112_CR32","first-page":"84","volume":"18","author":"M Gundogdu","year":"2020","unstructured":"Gundogdu M, Kundakci N, Erdem C. Assessment of Life Quality Index and Treatment Efficacy in Psoriasis Vulgaris Patients Receiving Biologic Therapies in a Turkish Population. Skinmed. 2020;18(2):84\u201390.","journal-title":"Skinmed"},{"issue":"4","key":"1112_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40257-021-00598-4","volume":"22","author":"T Torres","year":"2021","unstructured":"Torres T, Puig L, Vender R, Lynde C, Piaserico S, Carrascosa JM, Gisondi P, Daud\u00e9n E, Conrad C, Mendes-Bastos P, et al. Drug Survival of IL-12\/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study. Am J Clin Dermatol. 2021;22(4):567\u201379.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"1112_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2340\/00015555-1719","volume":"94","author":"S Piaserico","year":"2014","unstructured":"Piaserico S, Conti A, Lo Console F, De Simone C, Prestinari F, Mazzotta A, Gualdi G, Guarneri C, Borsari S, Cassano N. Efficacy and safety of systemic treatments for psoriasis in elderly patients. Acta Derm Venereol. 2014;94(3):293\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"1112_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/1346-8138.15247","volume":"47","author":"C Ohata","year":"2020","unstructured":"Ohata C, Ohyama B, Katayama E, Nakama T. Real-world efficacy and safety of interleukin-17 inhibitors for psoriasis: A single-center experience. J Dermatol. 2020;47(4):405\u20138.","journal-title":"J Dermatol"},{"issue":"9","key":"1112_CR36","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/annrheumdis-2020-217927","volume":"79","author":"M Fauny","year":"2020","unstructured":"Fauny M, Moulin D, D\u2019Amico F, Netter P, Petitpain N, Arnone D, Jouzeau JY, Loeuille D, Peyrin-Biroulet L. Paradoxical gastrointestinal effects of interleukin-17 blockers. Ann Rheum Dis. 2020;79(9):1132\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1112_CR37","doi-asserted-by":"publisher","first-page":"e12936","DOI":"10.1111\/dth.12936","volume":"32","author":"R Mala","year":"2019","unstructured":"Mala R, Fida M, Jorgaqi E, Vasili E. Efficacy of biologic therapies in psoriasis vulgaris. Dermatol Ther. 2019;32(4):e12936.","journal-title":"Dermatol Ther"},{"issue":"1","key":"1112_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Therapy. 2023;8(1):437.","journal-title":"Signal Transduct Target Therapy"},{"issue":"Suppl 1","key":"1112_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000501994","volume":"11","author":"D Kostaki","year":"2019","unstructured":"Kostaki D, Aquila E, Macaluso L, Mattozzi C, Richetta AG. Optimizing Secukinumab Treatment in Psoriasis with Concomitant Methotrexate Administration: Minireview and A Case Report. Case Rep Dermatol. 2019;11(Suppl 1):17\u201322.","journal-title":"Case Rep Dermatol"},{"key":"1112_CR40","doi-asserted-by":"publisher","first-page":"625130","DOI":"10.3389\/fmed.2021.625130","volume":"8","author":"P Liu","year":"2021","unstructured":"Liu P, Peng C, Chen X, Wu L, Yin M, Li J, Qin Q, Kuang Y, Zhu W. Acitretin Promotes the Differentiation of Myeloid-Derived Suppressor Cells in the Treatment of Psoriasis. Front Med (Lausanne). 2021;8:625130.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1112_CR41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s40001-025-02700-6","volume":"30","author":"H Wang","year":"2025","unstructured":"Wang H, Deng T, Wang J, Bai X, Shen Y, Qiu Y. Investigating the efficacy of calcipotriol-acitretin combination therapy versus monotherapy protocols in psoriasis and its effect on serum inflammatory factors: a systematic review and meta-analysis. Eur J Med Res. 2025;30(1):501.","journal-title":"Eur J Med Res"},{"issue":"5","key":"1112_CR42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/1744666X.2023.2185775","volume":"19","author":"JM Xu","year":"2023","unstructured":"Xu JM, Wang HM, Jin HZ. An update on therapeutic options for palmoplantar pustulosis: a narrative review and expert recommendations. Expert Rev Clin Immunol. 2023;19(5):499\u2013516.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"1112_CR43","first-page":"731","volume":"18","author":"L Bonomo","year":"2019","unstructured":"Bonomo L, Abittan BJ, Hashim PW, Karki C, Mason M, Lebwohl M. Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry. J Drugs Dermatol. 2019;18(8):731\u201340.","journal-title":"J Drugs Dermatol"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01112-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01112-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01112-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:46:14Z","timestamp":1784846774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01112-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01112-4","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Guangzhou Dermatology Hospital. All procedures involving human participants adhered to ethical standards set by the institutional and national research committees, as well as the 1964 Declaration of Helsinki and its amendments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"100"}}